Global Central Lab Market by End User (Pharmaceutical Companies, Academic & Research Institutes, Biotechnology Companies), by Service Type (Specimen Management & Storage, Genetic Services, Biomarker Services, Anatomic Pathology/Histology, Microbiology Services, Special Chemistry Services, Clinical Research & Trial Services) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Central Lab Market research report which is segmented by End User (Pharmaceutical Companies, Academic & Research Institutes, Biotechnology Companies), by Service Type (Specimen Management & Storage, Genetic Services, Biomarker Services, Anatomic Pathology/Histology, Microbiology Services, Special Chemistry Services, Clinical Research & Trial Services), By Players/Companies Eurofins Global Central Library, PPD Central Lab and Q² Solutions, Medpace Reference Laboratory, Covance (Labcorp), ICON Central Labs”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Central Lab Market Research Report |
| By End User | Pharmaceutical Companies, Academic & Research Institutes, Biotechnology Companies |
| By Service Type | Specimen Management & Storage, Genetic Services, Biomarker Services, Anatomic Pathology/Histology, Microbiology Services, Special Chemistry Services, Clinical Research & Trial Services |
| By Companies | Eurofins Global Central Library, PPD Central Lab and Q² Solutions, Medpace Reference Laboratory, Covance (Labcorp), ICON Central Labs |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 220 |
| Number of Tables & Figures | 154 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Central Lab Market Report Segments:
The market is segmented by End User (Pharmaceutical Companies, Academic & Research Institutes, Biotechnology Companies), by Service Type (Specimen Management & Storage, Genetic Services, Biomarker Services, Anatomic Pathology/Histology, Microbiology Services, Special Chemistry Services, Clinical Research & Trial Services).
Central Lab Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Central Lab Market
Overview of the regional outlook of the Central Lab Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Central Lab Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Central Lab Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Pharmaceutical Companies
2. Academic & Research Institutes
3. Biotechnology Companies
7. By Service Type:1. Specimen Management & Storage
2. Genetic Services
3. Biomarker Services
4. Anatomic Pathology/Histology
5. Microbiology Services
6. Special Chemistry Services
7. Clinical Research & Trial Services
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Central Lab Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Central Lab Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Central Lab Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Central Lab Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Central Lab Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Central Lab Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Central Lab Market Size & Forecast, 2018-2028
4.5.1 Central Lab Market Size and Y-o-Y Growth
4.5.2 Central Lab Market Absolute $ Opportunity
Chapter 5 Global Central Lab Market Analysis and Forecast by End User
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End User
5.1.2 Basis Point Share (BPS) Analysis by End User
5.1.3 Absolute $ Opportunity Assessment by End User
5.2 Central Lab Market Size Forecast by End User
5.2.1 Pharmaceutical Companies
5.2.2 Academic & Research Institutes
5.2.3 Biotechnology Companies
5.3 Market Attractiveness Analysis by End User
Chapter 6 Global Central Lab Market Analysis and Forecast by Service Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Service Type
6.1.2 Basis Point Share (BPS) Analysis by Service Type
6.1.3 Absolute $ Opportunity Assessment by Service Type
6.2 Central Lab Market Size Forecast by Service Type
6.2.1 Specimen Management & Storage
6.2.2 Genetic Services
6.2.3 Biomarker Services
6.2.4 Anatomic Pathology/Histology
6.2.5 Microbiology Services
6.2.6 Special Chemistry Services
6.2.7 Clinical Research & Trial Services
6.3 Market Attractiveness Analysis by Service Type
Chapter 7 Global Central Lab Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Central Lab Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Central Lab Analysis and Forecast
9.1 Introduction
9.2 North America Central Lab Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Central Lab Market Size Forecast by End User
9.6.1 Pharmaceutical Companies
9.6.2 Academic & Research Institutes
9.6.3 Biotechnology Companies
9.7 Basis Point Share (BPS) Analysis by End User
9.8 Absolute $ Opportunity Assessment by End User
9.9 Market Attractiveness Analysis by End User
9.10 North America Central Lab Market Size Forecast by Service Type
9.10.1 Specimen Management & Storage
9.10.2 Genetic Services
9.10.3 Biomarker Services
9.10.4 Anatomic Pathology/Histology
9.10.5 Microbiology Services
9.10.6 Special Chemistry Services
9.10.7 Clinical Research & Trial Services
9.11 Basis Point Share (BPS) Analysis by Service Type
9.12 Absolute $ Opportunity Assessment by Service Type
9.13 Market Attractiveness Analysis by Service Type
Chapter 10 Europe Central Lab Analysis and Forecast
10.1 Introduction
10.2 Europe Central Lab Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Central Lab Market Size Forecast by End User
10.6.1 Pharmaceutical Companies
10.6.2 Academic & Research Institutes
10.6.3 Biotechnology Companies
10.7 Basis Point Share (BPS) Analysis by End User
10.8 Absolute $ Opportunity Assessment by End User
10.9 Market Attractiveness Analysis by End User
10.10 Europe Central Lab Market Size Forecast by Service Type
10.10.1 Specimen Management & Storage
10.10.2 Genetic Services
10.10.3 Biomarker Services
10.10.4 Anatomic Pathology/Histology
10.10.5 Microbiology Services
10.10.6 Special Chemistry Services
10.10.7 Clinical Research & Trial Services
10.11 Basis Point Share (BPS) Analysis by Service Type
10.12 Absolute $ Opportunity Assessment by Service Type
10.13 Market Attractiveness Analysis by Service Type
Chapter 11 Asia Pacific Central Lab Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Central Lab Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Central Lab Market Size Forecast by End User
11.6.1 Pharmaceutical Companies
11.6.2 Academic & Research Institutes
11.6.3 Biotechnology Companies
11.7 Basis Point Share (BPS) Analysis by End User
11.8 Absolute $ Opportunity Assessment by End User
11.9 Market Attractiveness Analysis by End User
11.10 Asia Pacific Central Lab Market Size Forecast by Service Type
11.10.1 Specimen Management & Storage
11.10.2 Genetic Services
11.10.3 Biomarker Services
11.10.4 Anatomic Pathology/Histology
11.10.5 Microbiology Services
11.10.6 Special Chemistry Services
11.10.7 Clinical Research & Trial Services
11.11 Basis Point Share (BPS) Analysis by Service Type
11.12 Absolute $ Opportunity Assessment by Service Type
11.13 Market Attractiveness Analysis by Service Type
Chapter 12 Latin America Central Lab Analysis and Forecast
12.1 Introduction
12.2 Latin America Central Lab Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Central Lab Market Size Forecast by End User
12.6.1 Pharmaceutical Companies
12.6.2 Academic & Research Institutes
12.6.3 Biotechnology Companies
12.7 Basis Point Share (BPS) Analysis by End User
12.8 Absolute $ Opportunity Assessment by End User
12.9 Market Attractiveness Analysis by End User
12.10 Latin America Central Lab Market Size Forecast by Service Type
12.10.1 Specimen Management & Storage
12.10.2 Genetic Services
12.10.3 Biomarker Services
12.10.4 Anatomic Pathology/Histology
12.10.5 Microbiology Services
12.10.6 Special Chemistry Services
12.10.7 Clinical Research & Trial Services
12.11 Basis Point Share (BPS) Analysis by Service Type
12.12 Absolute $ Opportunity Assessment by Service Type
12.13 Market Attractiveness Analysis by Service Type
Chapter 13 Middle East & Africa (MEA) Central Lab Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Central Lab Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Central Lab Market Size Forecast by End User
13.6.1 Pharmaceutical Companies
13.6.2 Academic & Research Institutes
13.6.3 Biotechnology Companies
13.7 Basis Point Share (BPS) Analysis by End User
13.8 Absolute $ Opportunity Assessment by End User
13.9 Market Attractiveness Analysis by End User
13.10 Middle East & Africa (MEA) Central Lab Market Size Forecast by Service Type
13.10.1 Specimen Management & Storage
13.10.2 Genetic Services
13.10.3 Biomarker Services
13.10.4 Anatomic Pathology/Histology
13.10.5 Microbiology Services
13.10.6 Special Chemistry Services
13.10.7 Clinical Research & Trial Services
13.11 Basis Point Share (BPS) Analysis by Service Type
13.12 Absolute $ Opportunity Assessment by Service Type
13.13 Market Attractiveness Analysis by Service Type
Chapter 14 Competition Landscape
14.1 Central Lab Market: Competitive Dashboard
14.2 Global Central Lab Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eurofins Global Central Library
14.3.2 PPD Central Lab and Q² Solutions
14.3.3 Medpace Reference Laboratory
14.3.4 Covance (Labcorp)
14.3.5 ICON Central Labs
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Central Lab Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Central Lab Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Central Lab Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Central Lab Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Central Lab Market Size & Forecast, 2018-2028
4.5.1 Central Lab Market Size and Y-o-Y Growth
4.5.2 Central Lab Market Absolute $ Opportunity
Chapter 5 Global Central Lab Market Analysis and Forecast by End User
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End User
5.1.2 Basis Point Share (BPS) Analysis by End User
5.1.3 Absolute $ Opportunity Assessment by End User
5.2 Central Lab Market Size Forecast by End User
5.2.1 Pharmaceutical Companies
5.2.2 Academic & Research Institutes
5.2.3 Biotechnology Companies
5.3 Market Attractiveness Analysis by End User
Chapter 6 Global Central Lab Market Analysis and Forecast by Service Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Service Type
6.1.2 Basis Point Share (BPS) Analysis by Service Type
6.1.3 Absolute $ Opportunity Assessment by Service Type
6.2 Central Lab Market Size Forecast by Service Type
6.2.1 Specimen Management & Storage
6.2.2 Genetic Services
6.2.3 Biomarker Services
6.2.4 Anatomic Pathology/Histology
6.2.5 Microbiology Services
6.2.6 Special Chemistry Services
6.2.7 Clinical Research & Trial Services
6.3 Market Attractiveness Analysis by Service Type
Chapter 7 Global Central Lab Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Central Lab Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Central Lab Analysis and Forecast
9.1 Introduction
9.2 North America Central Lab Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Central Lab Market Size Forecast by End User
9.6.1 Pharmaceutical Companies
9.6.2 Academic & Research Institutes
9.6.3 Biotechnology Companies
9.7 Basis Point Share (BPS) Analysis by End User
9.8 Absolute $ Opportunity Assessment by End User
9.9 Market Attractiveness Analysis by End User
9.10 North America Central Lab Market Size Forecast by Service Type
9.10.1 Specimen Management & Storage
9.10.2 Genetic Services
9.10.3 Biomarker Services
9.10.4 Anatomic Pathology/Histology
9.10.5 Microbiology Services
9.10.6 Special Chemistry Services
9.10.7 Clinical Research & Trial Services
9.11 Basis Point Share (BPS) Analysis by Service Type
9.12 Absolute $ Opportunity Assessment by Service Type
9.13 Market Attractiveness Analysis by Service Type
Chapter 10 Europe Central Lab Analysis and Forecast
10.1 Introduction
10.2 Europe Central Lab Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Central Lab Market Size Forecast by End User
10.6.1 Pharmaceutical Companies
10.6.2 Academic & Research Institutes
10.6.3 Biotechnology Companies
10.7 Basis Point Share (BPS) Analysis by End User
10.8 Absolute $ Opportunity Assessment by End User
10.9 Market Attractiveness Analysis by End User
10.10 Europe Central Lab Market Size Forecast by Service Type
10.10.1 Specimen Management & Storage
10.10.2 Genetic Services
10.10.3 Biomarker Services
10.10.4 Anatomic Pathology/Histology
10.10.5 Microbiology Services
10.10.6 Special Chemistry Services
10.10.7 Clinical Research & Trial Services
10.11 Basis Point Share (BPS) Analysis by Service Type
10.12 Absolute $ Opportunity Assessment by Service Type
10.13 Market Attractiveness Analysis by Service Type
Chapter 11 Asia Pacific Central Lab Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Central Lab Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Central Lab Market Size Forecast by End User
11.6.1 Pharmaceutical Companies
11.6.2 Academic & Research Institutes
11.6.3 Biotechnology Companies
11.7 Basis Point Share (BPS) Analysis by End User
11.8 Absolute $ Opportunity Assessment by End User
11.9 Market Attractiveness Analysis by End User
11.10 Asia Pacific Central Lab Market Size Forecast by Service Type
11.10.1 Specimen Management & Storage
11.10.2 Genetic Services
11.10.3 Biomarker Services
11.10.4 Anatomic Pathology/Histology
11.10.5 Microbiology Services
11.10.6 Special Chemistry Services
11.10.7 Clinical Research & Trial Services
11.11 Basis Point Share (BPS) Analysis by Service Type
11.12 Absolute $ Opportunity Assessment by Service Type
11.13 Market Attractiveness Analysis by Service Type
Chapter 12 Latin America Central Lab Analysis and Forecast
12.1 Introduction
12.2 Latin America Central Lab Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Central Lab Market Size Forecast by End User
12.6.1 Pharmaceutical Companies
12.6.2 Academic & Research Institutes
12.6.3 Biotechnology Companies
12.7 Basis Point Share (BPS) Analysis by End User
12.8 Absolute $ Opportunity Assessment by End User
12.9 Market Attractiveness Analysis by End User
12.10 Latin America Central Lab Market Size Forecast by Service Type
12.10.1 Specimen Management & Storage
12.10.2 Genetic Services
12.10.3 Biomarker Services
12.10.4 Anatomic Pathology/Histology
12.10.5 Microbiology Services
12.10.6 Special Chemistry Services
12.10.7 Clinical Research & Trial Services
12.11 Basis Point Share (BPS) Analysis by Service Type
12.12 Absolute $ Opportunity Assessment by Service Type
12.13 Market Attractiveness Analysis by Service Type
Chapter 13 Middle East & Africa (MEA) Central Lab Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Central Lab Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Central Lab Market Size Forecast by End User
13.6.1 Pharmaceutical Companies
13.6.2 Academic & Research Institutes
13.6.3 Biotechnology Companies
13.7 Basis Point Share (BPS) Analysis by End User
13.8 Absolute $ Opportunity Assessment by End User
13.9 Market Attractiveness Analysis by End User
13.10 Middle East & Africa (MEA) Central Lab Market Size Forecast by Service Type
13.10.1 Specimen Management & Storage
13.10.2 Genetic Services
13.10.3 Biomarker Services
13.10.4 Anatomic Pathology/Histology
13.10.5 Microbiology Services
13.10.6 Special Chemistry Services
13.10.7 Clinical Research & Trial Services
13.11 Basis Point Share (BPS) Analysis by Service Type
13.12 Absolute $ Opportunity Assessment by Service Type
13.13 Market Attractiveness Analysis by Service Type
Chapter 14 Competition Landscape
14.1 Central Lab Market: Competitive Dashboard
14.2 Global Central Lab Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eurofins Global Central Library
14.3.2 PPD Central Lab and Q² Solutions
14.3.3 Medpace Reference Laboratory
14.3.4 Covance (Labcorp)
14.3.5 ICON Central Labs
Segments Covered in the Report
The global Central Lab market has been segmented based on
By End User
The global Central Lab market has been segmented based on
By End User
- Pharmaceutical Companies
- Academic & Research Institutes
- Biotechnology Companies
- Specimen Management & Storage
- Genetic Services
- Biomarker Services
- Anatomic Pathology/Histology
- Microbiology Services
- Special Chemistry Services
- Clinical Research & Trial Services
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Eurofins Global Central Library
- PPD Central Lab and Q² Solutions
- Medpace Reference Laboratory
- Covance (Labcorp)
- ICON Central Labs
Our Clients
Related Reports
Some other reports from this category!
